Novel glycidyl methacrylated dextran/gelatin nanoparticles loaded with basic fibroblast growth factor: formulation and characteristics

Drug Development and Industrial Pharmacy
Chunhu GuDinghua Yi

Abstract

To develop a novel efficient nanoparticulate carrier loaded with basic fibroblast growth factor (bFGF). Gelatin and glycidyl methacrylate-derivatized dextran (dex-GMA) were cross-linked and polymerized to form interpenetrating polymeric networks. The properties of the nanoparticles (NPs) were investigated as a function of the degree of dex-GMA substitution and the concentration of gelatin used in the preparation of the hydrogels. The morphology was observed with scanning eletromicroscopy and transmission eletromicroscopy. The swelling, degradation, and entrapment efficiency were also determined by dynamic evaluation methods in vitro. The protein release ratio and in vitro release kinetics were evaluated by routine procedure, and the biological activity of bFGF-loaded NPs was studied by cell proliferation assay, cell attachment, and cell function. The NPs have a particle size of 320 +/- 20 nm. bFGF was entrapped in the nanoparticles quantitatively (the encapsulation efficiency, 89.6 +/- 0.9%). The bFGF in vitro release kinetics fitted to zero-order and Higuchi equations. Proliferation assay, attachment assay, and western blot showed that bFGF NPs had good biological effects on cultured bone marrow mesenchymal stem cells and coul...Continue Reading

References

Jan 1, 1991·Annals of the New York Academy of Sciences·D Gospodarowicz
Jul 1, 1988·The Journal of Surgical Research·G S McGeeA A Demetriou
Jan 1, 1981·Journal of Supramolecular Structure and Cellular Biochemistry·S K AkiyamaM Hayashi
Mar 13, 1999·The Journal of Clinical Investigation·S MakinoS Ogawa
Sep 15, 1999·Proceedings of the National Academy of Sciences of the United States of America·G C KopenD G Phinney
Dec 22, 1999·Journal of Biomedical Materials Research·S H Kim, C C Chu
Feb 24, 2001·Yonsei Medical Journal·H Suh
Apr 3, 2001·International Journal of Pharmaceutics·R J StenekesW E Hennink
May 4, 2001·Journal of Biomaterials Science. Polymer Edition·M YamamotoY Tabata
Jan 5, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·J A CadéeW E Hennink
Mar 12, 2003·Advanced Drug Delivery Reviews·Jayanth Panyam, Vinod Labhasetwar
Nov 2, 2005·International Journal of Pharmaceutics·Fa-ming ChenYan Jin
Nov 4, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Simon YoungAntonios G Mikos
Jul 25, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fa-ming ChenYan Jin
Oct 24, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Siwar Chayed, Françoise M Winnik
Nov 23, 2007·Advanced Drug Delivery Reviews·Marco BiondiPaolo Antonio Netti
Dec 18, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Raghavendra C MundargiTejraj M Aminabhavi
Jun 10, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lara Jabr-MilaneMansoor Amiji
Feb 10, 2009·Journal of Nanoscience and Nanotechnology·Mohd Zobir HusseinAsmah Hj Yahaya

❮ Previous
Next ❯

Citations

Dec 4, 2010·Drug Development and Industrial Pharmacy·Chidambaram SoundrapandianSomeswar Datta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.